Congestive heart failure causes: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(30 intermediate revisions by 7 users not shown)
Line 5: Line 5:
| [[Heart failure resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']]
| [[Heart failure resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']]
|}
|}
{{Congestive heart failure}}
{{Congestive heart failure}}
{{CMG}}
{{CMG}}


==Overview==
==Overview==
There are several classification schemes used to characterize the pathophysiology of heart failure as either [[systolic dysfunction|systolic]] vs [[diastolic dysfunction|diastolic]]; left vs right; or low output vs [[High output failure|high output]].  The anatomic structure underlying the disease process is often characterized as well.  The causes of heart failure are also often characterized by their chronicity (acute/decompensated or chronic).
There are several classification schemes used to characterize the pathophysiology of heart failure as either [[systolic dysfunction|systolic]] vs [[diastolic dysfunction|diastolic]]; left vs right; or low output vs [[High output failure|high output]].  The anatomic structure underlying the disease process is often characterized as well.  The causes of heart failure are also often characterized by their chronicity (acute/decompensated or chronic).


==Causes==
==Causes==
===Life Threatening Causes===
===Life Threatening Causes===
Congestive heart failure is life threatening and should be treated as such irrespective of the underlying cause
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.  Congestive heart failure is life threatening and should be treated as such irrespective of the underlying cause.
 
===Common Causes===
===Common Causes===
*[[Arrhythmias]]
*[[Arrhythmias]]
*[[Cardiomyopathy|Cardiomyopathies]]
*[[Cardiomyopathy|Cardiomyopathies]]
*[[Cardiotoxicity|Cardiotoxins]] e.g., [[alcohol]], [[cocaine]], [[Aprotinin]].
*[[Cardiotoxicity|Cardiotoxins (e.g., alcohol, cocaine, aprotinin)]]
*[[Congenital heart disease]]
*[[Congenital heart disease]]
*[[Hypertension]]
*[[Hypertension]]
Line 31: Line 30:
{|style="width:75%; height:100px" border="1"
{|style="width:75%; height:100px" border="1"
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" |'''Cardiovascular'''
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" |'''Cardiovascular'''
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" |[[Aortic regurgitation]], [[aortic stenosis]], [[arrhythmias]], [[arrhythmogenic right ventricular dysplasia]], [[arteriovenous fistula]], [[atrial fibrillation]], [[atrial septal defect]], [[cardiac amyloidosis]], [[aneurysm|cardiac aneurysm]], [[congenital heart disease]], [[constrictive pericarditis]], [[dilated cardiomyopathy]], [[eisenmenger syndrome]], [[endocarditis]], [[hypertension]], [[hypertrophic cardiomyopathy]], [[hypoplastic left heart syndrome]], [[Interferon gamma]], [[ischemic heart disease]], [[malignant hypertension]], [[mitral regurgitation]], [[mitral stenosis]], [[myocardial infarction]], [[Oxaprozin]], [[patent ductus arteriosus]], [[pericardial effusion]], [[pericardial tamponade]], [[pericarditis]], [[peripartum cardiomyopathy]], [[Pertuzumab]], [[restrictive cardiomyopathy]], [[rheumatic fever|rheumatic carditis]], [[rupture of the papillary muscles]], [[Takotsubo cardiomyopathy]], [[tricuspid insufficiency]], [[valvular heart disease]], [[ventricular aneurysm]], [[ventricular septal defect]]  
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" |[[Aortic regurgitation]], [[aortic stenosis]], [[arrhythmias]], [[arrhythmogenic right ventricular dysplasia]], [[arteriovenous fistula]], [[atrial fibrillation]], [[atrial septal defect]], [[cardiac amyloidosis]], [[aneurysm|cardiac aneurysm]], [[congenital heart disease]], [[constrictive pericarditis]], [[dilated cardiomyopathy]], [[Eisenmenger syndrome]], [[endocarditis]], [[hypertension]], [[hypertrophic cardiomyopathy]], [[hypoplastic left heart syndrome]], [[interferon gamma]], [[ischemic heart disease]], [[malignant hypertension]], [[mitral regurgitation]], [[mitral stenosis]], [[myocardial infarction]], [[oxaprozin]], [[patent ductus arteriosus]], [[pericardial effusion]], [[pericardial tamponade]], [[pericarditis]], [[peripartum cardiomyopathy]], [[pertuzumab]], [[restrictive cardiomyopathy]], [[rheumatic fever|rheumatic carditis]], [[rupture of the papillary muscles]], [[Takotsubo cardiomyopathy]], [[tricuspid insufficiency]], [[valvular heart disease]], [[ventricular aneurysm]], [[ventricular septal defect]]  
|-
|-
|bgcolor="LightSteelBlue"| '''Chemical/Poisoning'''
|bgcolor="LightSteelBlue"| '''Chemical/Poisoning'''
Line 46: Line 45:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Drug Side Effect'''
| '''Drug Side Effect'''
|bgcolor="Beige"| [[Bicalutamide]], [[Carfilzomib]], [[Certolizumab pegol]], [[Cidofovir]], [[Cinacalcet]], [[Cyclophosphamide]], [[Dexamethasone]], [[Disulfiram]],[[Dornase Alfa]], [[Doxorubicin Hydrochloride]], [[Epirubicin ]],  [[Epoetin Alfa]], [[Felbamate]], [[Flurbiprofen]], [[Goserelin]], [[Idarubicin hydrochloride]], [[Imatinib]], [[Levothyroxine]], [[Mefenamic acid]], [[Meloxicam]], [[Meropenem]], [[Methylprednisolone]], [[Metoclopramide]], [[Mitomycin]], [[Mitoxantrone]], [[Muromonab-CD3]], [[Nilutamide]], [[Oxcarbazepine]], [[Pergolide]], [[Phenylbutazone]], [[Piroxicam]],  [[Ponatinib hydrochloride]],[[Pramipexole]], [[prednisone]], [[prednisolone]], [[Sorafenib]], [[Sulindac]], [[Sunitinib malate]], [[Trastuzumab]], [[Valdecoxib]], [[vandetanib]]
|bgcolor="Beige"| [[Ado-trastuzumab emtansine]], [[bicalutamide]],[[bicisate dihydrochloride]], [[carfilzomib]], [[certolizumab pegol]], [[cidofovir]], [[cinacalcet]], [[cyclophosphamide]], [[dexamethasone]], [[diclofenac (patch)]], [[disulfiram]],[[dornase alfa]], [[doxorubicin hydrochloride]], [[epirubicin ]],  [[epoetin alfa]], [[felbamate]], [[ferumoxytol]], [[flurbiprofen]], [[goserelin]], [[hydroxyethyl starch]], [[ibuprofen lysine]], [[idarubicin hydrochloride]], [[idursulfase]], [[imatinib]], [[ixabepilone]], [[levothyroxine]], [[mefenamic acid]], [[meloxicam]], [[meropenem]], [[methoxy polyethylene glycol-epoetin beta]], [[methylprednisolone]], [[metoclopramide]], [[mitomycin]], [[mitoxantrone]], [[muromonab-CD3]], [[nilutamide]], [[nitroglycerin]],[[oprelvekin]], [[oxcarbazepine]], [[Peginterferon Beta-1a]],[[pergolide]], [[phenylbutazone]], [[piroxicam]],  [[ponatinib hydrochloride]], [[pramipexole]], [[prednisone]], [[prednisolone]], [[rubidium Rb 82]], [[sorafenib]], [[sulindac]], [[sunitinib malate]], [[tolmetin]], [[trastuzumab]], [[valdecoxib]], [[vandetanib]]


|-
|-
Line 79: Line 78:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Infectious Disease'''
| '''Infectious Disease'''
|bgcolor="Beige"|
|bgcolor="Beige"|[[Endocarditis]], [[human immunodeficiency virus]], [[Lyme disease]], [[pericarditis]], [[rheumatic fever|rheumatic carditis]], [[rheumatic fever]], [[sepsis]], [[viral myocarditis]], [[Whipple's disease]]
[[Endocarditis]],
[[human immunodeficiency virus]],
[[Lyme disease]],
[[pericarditis]],
[[rheumatic fever|rheumatic carditis]],
[[rheumatic fever]],
[[sepsis]],
[[viral myocarditis]],
[[Whipple's disease]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 100: Line 90:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Nutritional/Metabolic'''
| '''Nutritional/Metabolic'''
|bgcolor="Beige"|
|bgcolor="Beige"| [[Ascorbic acid deficiency]], [[beriberi]], [[carnitine deficiency]], [[glycogen storage disease]], [[hemochromatosis]], [[metabolic acidosis]], [[Paget's disease]]
[[Ascorbic acid deficiency]],
[[beriberi]],
[[carnitine deficiency]],
[[glycogen storage disease]],
[[hemochromatosis]],
[[metabolic acidosis]],  
[[Paget's disease]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 123: Line 106:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Overdose/Toxicity'''
| '''Overdose/Toxicity'''
|bgcolor="Beige"|
|bgcolor="Beige"| [[Alcohol]], [[atenolol]], [[dronedarone]], [[imatinib mesylate]], [[propranolol]], [[verapamil]]
[[Alcohol]],
[[atenolol]],
[[dronedarone]],
[[imatinib mesylate]],
[[propranolol]],
[[verapamil]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 137: Line 114:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Pulmonary'''
| '''Pulmonary'''
|bgcolor="Beige"|
|bgcolor="Beige"| [[Coalworker's pneumoconiosis]], [[cor pulmonale]], [[hypoxia]], [[Pickwickian syndrome]], [[pulmonary artery stenosis]], [[pulmonary embolism]], [[pulmonary fibrosis]], [[pulmonary hypertension]], [[pulmonary valve stenosis]], [[pulmonary vein stenosis]], [[pulmonic regurgitation]], [[silicosis]]
[[Coalworker's pneumoconiosis]],
[[cor pulmonale]],
[[hypoxia]],
[[Pickwickian syndrome]],
[[pulmonary artery stenosis]],
[[pulmonary embolism]],
[[pulmonary fibrosis]],
[[pulmonary hypertension]],
[[pulmonary valve stenosis]],
[[pulmonary vein stenosis]],
[[pulmonic regurgitation]],
[[silicosis]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 156: Line 121:
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Rheumatology/Immunology/Allergy'''
| '''Rheum/Immune/Allergy'''
|bgcolor="Beige"|
|bgcolor="Beige"| [[Cardiac amyloidosis]], [[sarcoidosis]], [[systemic lupus erythematosus]]
[[Cardiac amyloidosis]],
[[sarcoidosis]],
[[systemic lupus erythematosus]]  
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 181: Line 143:


===Causes in Alphabetical Order===
===Causes in Alphabetical Order===
{{col-begin|width=80%}}
{{columns-list|
{{col-break|width=33%}}
*[[Ado-trastuzumab emtansine]]
*[[Alcoholism]]
*[[Alcoholism]]
*[[Anemia]]
*[[Anemia]]
Line 195: Line 157:
*[[Atrial septal defect]]
*[[Atrial septal defect]]
*[[Beriberi]]
*[[Beriberi]]
*[[Bicalutamide]]
*[[Bicisate dihydrochloride]]
*[[Cardiac amyloidosis]]
*[[Cardiac amyloidosis]]
*[[Aneurysm|Cardiac aneurysm]]
*[[Aneurysm|Cardiac aneurysm]]
*[[Carfilzomib]]
*[[Carfilzomib]]
*[[Carnitine deficiency]]
*[[Carnitine deficiency]]
*[[Certolizumab pegol]]
*[[Cidofovir]]
*[[Cidofovir]]
*[[Cinacalcet]]
*[[Coalworker's pneumoconiosis]]
*[[Coalworker's pneumoconiosis]]
*[[Congenital heart disease]]
*[[Congenital heart disease]]
Line 207: Line 173:
*[[Dexamethasone]]
*[[Dexamethasone]]
*[[Diabetes mellitus]]
*[[Diabetes mellitus]]
*[[Diclofenac (patch)]]
*[[Dilated cardiomyopathy]]
*[[Dilated cardiomyopathy]]
*[[Disulfiram]]
*[[Dornase alfa]]
*[[Doxorubicin Hydrochloride]]
*[[Doxorubicin Hydrochloride]]
*[[Dronedarone]]
*[[Dronedarone]]
*[[Eisenmenger syndrome]]
*[[Eisenmenger syndrome]]
*[[Endocarditis]]
*[[Endocarditis]]
*[[Epirubicin]]
*[[Epoetin alfa]]
*[[Ethylene glycol]]
*[[Ethylene glycol]]
*[[Felbamate]]
*[[Ferumoxytol]]
*[[Flurbiprofen]]
*[[Flurbiprofen]]
*[[Friedreich's ataxia]]
*[[Friedreich's ataxia]]
*[[Glycogen storage disease]]
*[[Glycogen storage disease]]
*[[Goserelin]]
*[[Hemochromatosis]]
*[[Hemochromatosis]]
*[[Human immunodeficiency virus]]
*[[Human immunodeficiency virus]]
*[[Hydroxyethyl starch]]
*[[Hypertension]]
*[[Hypertension]]
*[[Hyperthyroidism]]
*[[Hyperthyroidism]]
Line 225: Line 200:
*[[Hypoxia]]
*[[Hypoxia]]
*[[Idarubicin hydrochloride]]
*[[Idarubicin hydrochloride]]
*[[Ibuprofen lysine]]
*[[Idursulfase]]
*[[Imatinib mesylate]]
*[[Imatinib mesylate]]
*[[Interferon gamma]]
*[[Interferon gamma]]
*[[Ischemic heart disease]]
*[[Ischemic heart disease]]
*[[Ixabepilone]]
*[[Levothyroxine]]
*[[Lyme disease]]
*[[Lyme disease]]
*[[Malignant hypertension]]
*[[Malignant hypertension]]
*[[Marfan's syndrome]]
*[[Marfan's syndrome]]
*[[Mefenamic acid]]
*[[Meloxicam]]
*[[Meloxicam]]
*[[Meropenem]]
*[[Metabolic acidosis]]
*[[Metabolic acidosis]]
{{col-break|width=33%}}
*[[Methoxy polyethylene glycol-epoetin beta]]
*[[Methylprednisolone]]
*[[Metoclopramide]]
*[[Mitomycin]]
*[[Mitoxantrone]]
*[[Mitral regurgitation]]
*[[Mitral regurgitation]]
*[[Mitral stenosis]]
*[[Mitral stenosis]]
*[[Mulibrey nanism|Mulibrey nanism syndrome]]
*[[Mulibrey nanism|Mulibrey nanism syndrome]]
*[[Muromonab-CD3]]
*[[Muscular dystrophy]]
*[[Muscular dystrophy]]
*[[Myocardial infarction]]
*[[Myocardial infarction]]
*[[Nilutamide]]
*[[Nilutamide]]
*[[Nitroglycerin]]
*[[Noonan syndrome]]
*[[Noonan syndrome]]
*[[Oprelvekin]]
*[[Oxaprozin]]
*[[Oxaprozin]]
*[[Paget's disease]]
*[[Paget's disease]]
*[[Pancoast's tumor]]
*[[Pancoast's tumor]]
*[[Patent ductus arteriosus]]
*[[Patent ductus arteriosus]]
*[[Peginterferon Beta-1a]]
*[[Pergolide]]
*[[Pergolide]]
*[[Pericardial effusion]]
*[[Pericardial effusion]]
Line 253: Line 242:
*[[Pickwickian syndrome]]
*[[Pickwickian syndrome]]
*[[Piroxicam]]
*[[Piroxicam]]
*[[Pneumococcal Vaccine 13-Valent]] ([[Prevnar 13]]): in infants and toddlers
*[[Ponatinib hydrochloride]]
*[[Pneumococcal Vaccine 13-Valent]] ([[Prevnar 13]])
*[[Pramipexole]]
*[[Propranolol]]
*[[Propranolol]]
*[[Prednisone]]
*[[Prednisone]]
*[[Prednisolone]]
*[[Pulmonary artery stenosis]]
*[[Pulmonary artery stenosis]]
*[[Pulmonary embolism]]
*[[Pulmonary embolism]]
Line 266: Line 258:
*[[Rheumatic fever|Rheumatic carditis]]
*[[Rheumatic fever|Rheumatic carditis]]
*[[Rheumatic fever]]
*[[Rheumatic fever]]
*[[Rubidium Rb 82]]
*[[Rupture of the papillary muscles]]
*[[Rupture of the papillary muscles]]
*[[Sarcoidosis]]
*[[Sarcoidosis]]
Line 271: Line 264:
*[[Silicosis]]
*[[Silicosis]]
*[[Sorafenib]]
*[[Sorafenib]]
*[[Sulindac]]
*[[Sunitinib malate]]
*[[Sunitinib malate]]
*[[Systemic lupus erythematosus]]
*[[Systemic lupus erythematosus]]
*[[Takotsubo cardiomyopathy]]
*[[Takotsubo cardiomyopathy]]
*[[Thyrotoxicosis]]
*[[Thyrotoxicosis]]
*[[Tolmetin]]
*[[Trastuzumab]]
*[[Trastuzumab]]
*[[Tricuspid insufficiency]]
*[[Tricuspid insufficiency]]
*[[Valdecoxib]]
*[[Vandetanib]]
*[[Valvular heart disease]]
*[[Valvular heart disease]]
*[[Ventricular aneurysm]]
*[[Ventricular aneurysm]]
Line 283: Line 280:
*[[Viral myocarditis]]
*[[Viral myocarditis]]
*[[Whipple's disease]]
*[[Whipple's disease]]
 
}}
 
 
{{col-end}}


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}


[[Category:Cardiology]]
[[Category:Cardiology]]
Line 296: Line 292:
[[Category:Intensive care medicine]]
[[Category:Intensive care medicine]]
[[Category:Medicine]]
[[Category:Medicine]]
[[Category:Primary care]]
[[Category:Up-To-Date]]
[[Category:Up-To-Date]]
[[Category:Up-To-Date cardiology]]
[[Category:Up-To-Date cardiology]]
[[Category:Crowdiagnosis]]
[[Category:Crowdiagnosis]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 21:05, 29 July 2020



Resident
Survival
Guide
Congestive Heart Failure Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Systolic Dysfunction
Diastolic Dysfunction
HFpEF
HFrEF

Causes

Differentiating Congestive heart failure from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Clinical Assessment

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Cardiac MRI

Echocardiography

Exercise Stress Test

Myocardial Viability Studies

Cardiac Catheterization

Other Imaging Studies

Other Diagnostic Studies

Treatment

Invasive Hemodynamic Monitoring

Medical Therapy:

Summary
Acute Pharmacotherapy
Chronic Pharmacotherapy in HFpEF
Chronic Pharmacotherapy in HFrEF
Diuretics
ACE Inhibitors
Angiotensin receptor blockers
Aldosterone Antagonists
Beta Blockers
Ca Channel Blockers
Nitrates
Hydralazine
Positive Inotropics
Anticoagulants
Angiotensin Receptor-Neprilysin Inhibitor
Antiarrhythmic Drugs
Nutritional Supplements
Hormonal Therapies
Drugs to Avoid
Drug Interactions
Treatment of underlying causes
Associated conditions

Exercise Training

Surgical Therapy:

Biventricular Pacing or Cardiac Resynchronization Therapy (CRT)
Implantation of Intracardiac Defibrillator
Ultrafiltration
Cardiac Surgery
Left Ventricular Assist Devices (LVADs)
Cardiac Transplantation

ACC/AHA Guideline Recommendations

Initial and Serial Evaluation of the HF Patient
Hospitalized Patient
Patients With a Prior MI
Sudden Cardiac Death Prevention
Surgical/Percutaneous/Transcather Interventional Treatments of HF
Patients at high risk for developing heart failure (Stage A)
Patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B)
Patients with current or prior symptoms of heart failure (Stage C)
Patients with refractory end-stage heart failure (Stage D)
Coordinating Care for Patients With Chronic HF
Quality Metrics/Performance Measures

Implementation of Practice Guidelines

Congestive heart failure end-of-life considerations

Specific Groups:

Special Populations
Patients who have concomitant disorders
Obstructive Sleep Apnea in the Patient with CHF
NSTEMI with Heart Failure and Cardiogenic Shock

Congestive heart failure causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Congestive heart failure causes

CDC on Congestive heart failure causes

Congestive heart failure causes in the news

Blogs on Congestive heart failure causes

Directions to Hospitals Treating Congestive heart failure causes

Risk calculators and risk factors for Congestive heart failure causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

There are several classification schemes used to characterize the pathophysiology of heart failure as either systolic vs diastolic; left vs right; or low output vs high output. The anatomic structure underlying the disease process is often characterized as well. The causes of heart failure are also often characterized by their chronicity (acute/decompensated or chronic).

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Congestive heart failure is life threatening and should be treated as such irrespective of the underlying cause.

Common Causes

Causes by Organ System

Cardiovascular Aortic regurgitation, aortic stenosis, arrhythmias, arrhythmogenic right ventricular dysplasia, arteriovenous fistula, atrial fibrillation, atrial septal defect, cardiac amyloidosis, cardiac aneurysm, congenital heart disease, constrictive pericarditis, dilated cardiomyopathy, Eisenmenger syndrome, endocarditis, hypertension, hypertrophic cardiomyopathy, hypoplastic left heart syndrome, interferon gamma, ischemic heart disease, malignant hypertension, mitral regurgitation, mitral stenosis, myocardial infarction, oxaprozin, patent ductus arteriosus, pericardial effusion, pericardial tamponade, pericarditis, peripartum cardiomyopathy, pertuzumab, restrictive cardiomyopathy, rheumatic carditis, rupture of the papillary muscles, Takotsubo cardiomyopathy, tricuspid insufficiency, valvular heart disease, ventricular aneurysm, ventricular septal defect
Chemical/Poisoning Ethylene glycol
Dental No underlying causes
Dermatologic No underlying causes
Drug Side Effect Ado-trastuzumab emtansine, bicalutamide,bicisate dihydrochloride, carfilzomib, certolizumab pegol, cidofovir, cinacalcet, cyclophosphamide, dexamethasone, diclofenac (patch), disulfiram,dornase alfa, doxorubicin hydrochloride, epirubicin , epoetin alfa, felbamate, ferumoxytol, flurbiprofen, goserelin, hydroxyethyl starch, ibuprofen lysine, idarubicin hydrochloride, idursulfase, imatinib, ixabepilone, levothyroxine, mefenamic acid, meloxicam, meropenem, methoxy polyethylene glycol-epoetin beta, methylprednisolone, metoclopramide, mitomycin, mitoxantrone, muromonab-CD3, nilutamide, nitroglycerin,oprelvekin, oxcarbazepine, Peginterferon Beta-1a,pergolide, phenylbutazone, piroxicam, ponatinib hydrochloride, pramipexole, prednisone, prednisolone, rubidium Rb 82, sorafenib, sulindac, sunitinib malate, tolmetin, trastuzumab, valdecoxib, vandetanib
Ear Nose Throat No underlying causes
Endocrine Diabetes mellitus, hyperthyroidism, hypothyroidism, thyrotoxicosis
Environmental Coalworker's pneumoconiosis, silicosis
Gastroenterologic No underlying causes
Genetic Atrial septal defect, congenital heart disease, Friedreich's ataxia, glycogen storage disease, Marfan's syndrome, Mulibrey nanism syndrome, muscular dystrophy, Noonan syndrome, ventricular septal defect
Hematologic Severe anemia
Iatrogenic No underlying causes
Infectious Disease Endocarditis, human immunodeficiency virus, Lyme disease, pericarditis, rheumatic carditis, rheumatic fever, sepsis, viral myocarditis, Whipple's disease
Musculoskeletal/Orthopedic No underlying causes
Neurologic No underlying causes
Nutritional/Metabolic Ascorbic acid deficiency, beriberi, carnitine deficiency, glycogen storage disease, hemochromatosis, metabolic acidosis, Paget's disease
Obstetric/Gynecologic No underlying causes
Oncologic Pancoast tumor
Ophthalmologic No underlying causes
Overdose/Toxicity Alcohol, atenolol, dronedarone, imatinib mesylate, propranolol, verapamil
Psychiatric No underlying causes
Pulmonary Coalworker's pneumoconiosis, cor pulmonale, hypoxia, Pickwickian syndrome, pulmonary artery stenosis, pulmonary embolism, pulmonary fibrosis, pulmonary hypertension, pulmonary valve stenosis, pulmonary vein stenosis, pulmonic regurgitation, silicosis
Renal/Electrolyte No underlying causes
Rheum/Immune/Allergy Cardiac amyloidosis, sarcoidosis, systemic lupus erythematosus
Sexual No underlying causes
Trauma No underlying causes
Urologic No underlying causes
Miscellaneous No underlying causes

Causes in Alphabetical Order

References

Template:WikiDoc Sources